Co-Diagnostics, Inc.

Not Rated
  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: US1897631057
USD
1.39
-0.03 (-2.11%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationCash Flow
Co-Diagnostics, Inc. Cash flow Statement
Figures in Million
Consolidated Cash Flow Results
Dec'25
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
No of Months
12
12
12
12
12
12
Profit Before Tax
-48.00
-37.00
-38.00
-18.00
45.00
42.00
Adjustment
0.00
0.00
0.00
0.00
0.00
0.00
Changes In working Capital
-3.00
2.00
5.00
6.00
-2.00
-16.00
Cash Flow after changes in Working Capital
0.00
0.00
0.00
0.00
0.00
0.00
Cash Flow from Operating Activities
-29.00
-29.00
-22.00
6.00
41.00
28.00
Cash Flow from Investing Activities
26.00
17.00
15.00
-58.00
4.00
-5.00
Cash Flow from Financing Activities
11.00
0.00
-1.00
-14.00
0.00
19.00
Net Cash Inflow / Outflow
8.00
-11.00
-8.00
-65.00
45.00
42.00
Opening Cash & Cash Equivalents
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent of Subsidiaries under liquidations
0.00
0.00
0.00
0.00
0.00
0.00
Translation adjustment on reserves / op cash balances foreign subsidiaries
0.00
0.00
0.00
0.00
0.00
0.00
Effect of Foreign Exchange Fluctuations
0.00
0.00
0.00
0.00
0.00
0.00
Closing Cash & Cash Equivalent
0.00
0.00
0.00
0.00
0.00
0.00
Figures in USD Million
Seasonal companies are compared with the same quarter last year
Compare Cash Flow Results of Co-Diagnostics, Inc.
Markets Mojo
Figures in Million
consolidated Cash Flow Results
Markets Mojo
Markets Mojo
Change(USD)
Change(%)
Profit Before Tax
-48.511914
-19.44
-29.00
-149.55%
Adjustment
0
0
0.00
0.00%
Changes In working Capital
-3.167199
1.038
-4.00
-405.13%
Cash Flow after changes in Working Capital
0
0
0.00
0.00%
Cash Flow from Operating Activities
-29.136927
-12.712
-17.00
-129.21%
Cash Flow from Investing Activities
26.273407
0
26.00
0.00%
Cash Flow from Financing Activities
11.811583
28.638
-17.00
-58.76%
Net Cash Inflow / Outflow
8.948063
15.926
-7.00
-43.81%
Opening Cash & Cash Equivalents
0
0
0.00
0.00%
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0
0
0.00
0.00%
Cash & Cash Equivalent of Subsidiaries under liquidations
0
0
0.00
0.00%
Translation adjustment on reserves / op cash balances foreign subsidiaries
0
0
0.00
0.00%
Effect of Foreign Exchange Fluctuations
0
0
0.00
0.00%
Closing Cash & Cash Equivalent
0
0
0.00
0.00%
Cash Flow - Snapshot (Consolidated) - Dec'25
stock-summary

YoY Growth in year ended Dec 2025 is 0.06% vs -32.03% in Dec 2024

Dec'25
Dec'24
Change(%)
Cash Flow from Operating Activities
-29.14
-29.16
0.06%